AroCell Q4: Positive development continues
Research Update
2025-02-20
08:00
Redeye provides an in-depth take on the Q4 report, and we are encouraged to see a consecutive quarter of positive EBITDA. Sales were in line with our estimates, and we appreciate the company emphasising more focus on geographical expansion, both in Europe and Asia.
Oscar Bergman
Analyst Q&A
Closed
Oscar Bergman answered 2 questions.
Disclosures and disclaimers